Healthcare
UK commission proposes lifecycle regulation for healthcare AI
A UK commission recommended lifecycle-based regulation for AI-enabled medical devices, including staged authorization, real-world monitoring, sandboxes and clearer liability rules.
The UK’s National Commission into the Regulation of AI in Healthcare reportedly published recommendations for regulating AI-enabled medical devices. The proposed framework is described as proportionate and intended to cover the full product lifecycle across the health system.
The recommendations are organized around lifecycle regulation, shared system-wide responsibility, and trust and transparency. Proposed mechanisms include staged authorization, continuous real-world monitoring, regulatory sandboxes and clearer rules concerning liability.
The framework addresses a central challenge in healthcare AI: technologies can change after deployment, interact with clinical systems and produce risks that are not fully visible during initial approval. Continuous monitoring and staged authorization are intended to account for those characteristics.
The development matters internationally because medical-AI developers and healthcare providers increasingly operate across jurisdictions. A lifecycle-based UK approach could influence how companies document, deploy and monitor AI-enabled medical devices, although the source describes recommendations rather than a completed law.
Original source: Faegre Drinker